Literature DB >> 30291683

The health consequences of falsified medicines- A study of the published literature.

Mohammad Sofiqur Rahman1,2,3, Naoko Yoshida3, Hirohito Tsuboi3, Naoki Tomizu3, Jamie Endo3, Onishi Miyu3, Yoshio Akimoto1, Kazuko Kimura1.   

Abstract

OBJECTIVES: To analyse and present the literature describing the health consequences of falsified medicines, focusing on mortality and morbidity, as well as the scale of the issue, the geographic extent, the medicines affected, and the harm caused at both the individual and population levels.
METHODS: We searched for articles in PubMed, using pre-optimized keywords '(counterfeit OR fake OR bogus OR falsified OR spurious) AND (medicine OR drug)'. Searches up to February 2017 yielded 2006 hits, of which 1791 were full-length articles in English. Among them, we found 81 papers that qualitatively or quantitatively described 48 incidents in which falsified medicines caused patients to suffer serious adverse effects, injury, symptoms or death.
RESULTS: The distribution of incidents was examined according to the economic status of the countries involved, regional location in the world, therapeutic category of the medicines, number of incidents and victims by year, and characteristics of the falsified medicines. Among the 48 reported incidents, 27 (56.3%) occurred in developing countries and 21 (43.7%) in developed countries. These incidents involved a total of approximately 7200 casualties including 3604 deaths.
CONCLUSIONS: Despite the poor quality of much of the reported data, the results of this study indicate that all types of medications have been targeted for falsification, and falsified medicines have had a serious impact on the health of both adults and children worldwide, with similar numbers of incidents in developing and developed countries.
© 2018 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse effect; bogus medicine; counterfeit medicine; death; décès; effets indésirables; effets sur la santé; fake medicine; falsified medicine; faux médicaments; health effect; médicament de contrefaçon; médicament falsifié; spurious medicine

Mesh:

Substances:

Year:  2018        PMID: 30291683     DOI: 10.1111/tmi.13161

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

1.  Assessment of the Quality of Injectable Antibiotics in Benin.

Authors:  Angèle Modupè Dohou; Achille Loconon Yémoa; Dodji Boris Aurel Guidan; Seyive Hélène Solange Ahouandjinou; Ahmed Amoussa; Francis Moïse Dossou; Roland Marini Djang'eing'a; Olivia Dalleur
Journal:  Am J Trop Med Hyg       Date:  2022-06-06       Impact factor: 3.707

2.  I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines.

Authors:  Sylvester Senyo Ofori-Parku; Sung Eun Park
Journal:  BMC Public Health       Date:  2022-06-01       Impact factor: 4.135

3.  A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011-2013.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Uy Sokchamroeun; Tep Keila; Tey Sovannarith; Heng Bun Kiet; Eav Dararath; Yoshio Akimoto; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

4.  Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Erina Maeda; Andrea Vanessa Velasco Ibarra; Theingi Zin; Yoshio Akimoto; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  BMC Pharmacol Toxicol       Date:  2021-03-02       Impact factor: 2.483

5.  Clarification of the internal structure and factors of poor dissolution of substandard roxithromycin tablets by near-infrared chemical imaging.

Authors:  Mirai Sakuda; Naoko Yoshida; Tatsuo Koide; Tep Keila; Kazuko Kimura; Hirohito Tsuboi
Journal:  Int J Pharm       Date:  2021-01-20       Impact factor: 5.875

6.  Substandard and falsified medical products: bibliometric analysis and mapping of scientific research.

Authors:  Waleed M Sweileh
Journal:  Global Health       Date:  2021-09-23       Impact factor: 4.185

Review 7.  Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons.

Authors:  Ludwig Hoellein; Eliangiringa Kaale; Yonah Hebron Mwalwisi; Marco H Schulze; Carina Vetye-Maler; Ulrike Holzgrabe
Journal:  Risk Manag Healthc Policy       Date:  2022-04-29

8.  The ghost in the data: Evidence gaps and the problem of fake drugs in global health research.

Authors:  Sarah Hodges; Emma Garnett
Journal:  Glob Public Health       Date:  2020-03-31

9.  A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality.

Authors:  Dominic McManus; Bernard David Naughton
Journal:  BMJ Glob Health       Date:  2020-08

10.  How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?

Authors:  Wubshet Tesfaye; Solomon Abrha; Mahipal Sinnollareddy; Bruce Arnold; Andrew Brown; Cynthia Matthew; Victor M Oguoma; Gregory M Peterson; Jackson Thomas
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.